# BeOne Medicines Ltd.: insider transactions

ONC · Nasdaq · CIK 1651308 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/onc.md) · [Financials](/companies/onc/financials.md) · [Filings](/companies/onc/filings.md) · [Insiders](/companies/onc/insiders.md)

## All transactions: 12

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-09-10 | [Amgen Inc](/insiders/318154.md) | 10% owner | Purchase (P) | 165,529 | $302.0615 | $50.0m | [Form 4](/filings/0000899243-21-035731.md) |
| 2020-12-18 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 25,762 | $260.9465 | $6.7m | [Form 4](/filings/0000899243-20-034573.md) |
| 2020-12-17 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 74,624 | $260.5396 | $19.4m | [Form 4](/filings/0000899243-20-034372.md) |
| 2020-12-16 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 85,573 | $248.2612 | $21.2m | [Form 4](/filings/0000899243-20-034372.md) |
| 2020-12-15 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 67,941 | $239.3065 | $16.3m | [Form 4](/filings/0000899243-20-034372.md) |
| 2020-08-25 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 59,390 | $248.4859 | $14.8m | [Form 4](/filings/0000899243-20-023386.md) |
| 2020-08-24 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 59,390 | $239.0959 | $14.2m | [Form 4](/filings/0000899243-20-023319.md) |
| 2020-08-21 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 64,176 | $230.1797 | $14.8m | [Form 4](/filings/0000899243-20-023319.md) |
| 2020-08-20 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 64,176 | $234.9941 | $15.1m | [Form 4](/filings/0000899243-20-023107.md) |
| 2020-08-19 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 64,176 | $234.8768 | $15.1m | [Form 4](/filings/0000899243-20-023107.md) |
| 2020-08-18 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 40,000 | $230.1797 | $9.2m | [Form 4](/filings/0000899243-20-023107.md) |
| 2020-07-15 | [Amgen Inc](/insiders/318154.md) | 10% owner | Grant or award (A) | 29,614,832 | $14.2308 | $421.4m | [Form 4](/filings/0000899243-20-019383.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 17:05 ET. No prices; not investment advice.